TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 4 | 1 | 2 | -7 | -1 | -11 | -31 | -8 |
| S | %wins | 75 | 75 | 75 | 75 | 100 | 100 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/11/12 19:44 | 10/9/12 | HSKA | Heska Corp | DE | Health | BioPrd | Biological Products, (No Diag | Cmc Master Fund, L.P. | CA | T | S.m | -113 | 9.50 | 0 | -12 | -2 | 530 | I | 122 | 20 | -14 | -7 | 22 | 7 | 5 | 0 | 0 | -3 | -13 | -10 | -13 | -36 | |
10/9/12 18:48 | 10/4/12 | HSKA | Heska Corp | DE | Health | BioPrd | Biological Products, (No Diag | Cmc Master Fund, L.P. | CA | T | S.m | -252 | 9.52 | 0 | -27 | -5 | 542 | I | 85 | 19 | -14 | -6 | 23 | 8 | 4 | 0 | 0 | -1 | -16 | -11 | -8 | -37 | |
10/4/12 15:15 | 10/2/12 | HSKA | Heska Corp | DE | Health | BioPrd | Biological Products, (No Diag | Cmc Master Fund, L.P. | CA | T | S.m | -105 | 9.54 | 0 | -11 | -2 | 568 | I | 113 | 16 | -16 | -10 | 18 | 8 | 6 | 5 | 0 | 0 | -13 | -9 | -5 | -39 | |
3/1/12 18:24 | 2/15/12 | HSKA | Heska Corp | DE | Health | BioPrd | Biological Products, (No Diag | Cmc Master Fund, L.P. | CA | T | S.m | -1,630 | 8.15 | 0 | -200 | -26 | 579 | I | 17 | 56 | 7 | 44 | 33 | 22 | 15 | 4 | 3 | 12 | 16 | 25 | -19 | -12 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |